Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis
Abstract Background Egypt has the highest hepatitis C virus prevalence worldwide where about 24% of the people are estimated to carry HCV and more than 50% of blood donors have anti-HCV in some towns. The burden of hepatocellular carcinoma has been increasing in Egypt with a doubling in the incidenc...
Main Authors: | Ayman Abdelghaffar Eldesoky, Nancy Abdel Fattah Ahmed, Hosam Eldeen Zaghloul, Amr Ahmed Abdel Aziz |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-11-01
|
Series: | Egyptian Liver Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43066-020-00062-8 |
Similar Items
-
Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
by: Nahla Anber, et al.
Published: (2020-02-01) -
Comparative Study of SIRT1 Expression in Hepatitis B Virus, Hepatitis C Virus, and Hepatocellular Carcinoma Patients
by: Ahmed Ibrahim, et al.
Published: (2022-04-01) -
Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
by: Helal F. Hetta, et al.
Published: (2020-07-01) -
Genomic Relevance of <i>FGFR2</i> on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
by: Walizeb Khan, et al.
Published: (2022-05-01) -
Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus-induced hepatocellular carcinoma
by: Ashraf Abbass, et al.
Published: (2024-03-01)